Repligen (RGEN) Capital Expenditures (2010 - 2026)

Repligen (RGEN) has 17 years of Capital Expenditures data on file, last reported at $237000.0 in Q1 2026.

• On a quarterly basis, Capital Expenditures fell 72.66% year-over-year to $237000.0 in Q1 2026; TTM through Mar 2026 was $1.6 million, a 120.81% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 569.43% from the prior year.
• Capital Expenditures for Q1 2026 stood at $237000.0, down from $484000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for RGEN reached as high as $20.5 million in Q3 2024 and fell as low as -$22.4 million in Q4 2023.
• Historically, Capital Expenditures has averaged $485588.2 across 5 years, with a median of $693000.0 in 2022.
• Across the five-year window, Capital Expenditures sank 2469.6% in 2023 and jumped 1645.45% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $944000.0 in 2022, then sank by 2469.6% to -$22.4 million in 2023, then advanced by 7.87% to -$20.6 million in 2024, then soared by 102.35% to $484000.0 in 2025, then slumped by 51.03% to $237000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $237000.0 in Q1 2026, $484000.0 in Q4 2025, and $180000.0 in Q3 2025.